Eugia US LLC is recalling 1,626 vials of Triamcinolone Acetonide Injectable Suspension, USP (400 mg per 10 mL). This recall was initiated because a piece of glass, measuring roughly 1 cm by 0.5 cm, was found inside a vial. This medication is typically used for intramuscular or intra-articular injections and should not be used if the product contains any visible particles.
The presence of glass particulates in an injectable medication poses a risk of local irritation, inflammation, or infection. If the glass fragment is injected, it could lead to more serious complications such as vascular damage or an embolism (a blockage in the blood vessels).
Manufactured in India for Auromedics Pharma LLC. Lot quantity: 1,626 vials.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.